Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
58.61
-1.00 (-1.68%)
At close: Nov 13, 2024, 4:00 PM
59.26
+0.65 (1.11%)
After-hours: Nov 13, 2024, 5:52 PM EST
Halozyme Therapeutics Operating Expense Breakdown
History
| Date | Cost of Sales | Selling, General, and Administrative | Research and Development | Amortization |
|---|---|---|---|---|
| Sep 30, 2024 | 169.66M | 149.69M | 79.94M | 71.05M |
| Jun 30, 2024 | 175.06M | 143.72M | 78.81M | 73.63M |
| Mar 31, 2024 | 185.52M | 146.96M | 77.50M | 73.70M |
| Dec 31, 2023 | 192.36M | 149.18M | 76.36M | 73.77M |
| Sep 30, 2023 | 182.18M | 149.32M | 77.59M | 60.56M |
| Jun 30, 2023 | 174.68M | 148.52M | 76.98M | 67.42M |
| Mar 31, 2023 | 158.55M | 167.05M | 72.73M | 60.98M |
| Dec 31, 2022 | 139.30M | 143.53M | 66.61M | 43.15M |
| Sep 30, 2022 | 118.77M | 119.55M | 54.15M | 38.60M |
| Jun 30, 2022 | 90.04M | 98.25M | 45.93M | 11.40M |
| Mar 31, 2022 | 79.12M | 53.10M | 38.52M | - |
| Dec 31, 2021 | 81.41M | 50.32M | 35.67M | - |
| Sep 30, 2021 | 86.10M | 46.98M | 32.94M | - |
| Jun 30, 2021 | 73.08M | 45.51M | 32.21M | - |
| Mar 31, 2021 | 55.80M | 44.16M | 33.09M | - |
| Dec 31, 2020 | 43.37M | 45.74M | 34.24M | - |
| Sep 30, 2020 | 33.78M | 59.24M | 71.97M | - |
| Jun 30, 2020 | 50.55M | 65.52M | 94.68M | - |
| Mar 31, 2020 | 46.68M | 71.88M | 119.63M | - |
| Dec 31, 2019 | 45.55M | 77.25M | 140.80M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.